Bio-Path Holdings (NASDAQ: BPTH): 2019 Earnings Snapshot

— Bio-Path Holdings Inc. (NASDAQ: BPTH) reported a loss of $3.24 share for the full year 2019, wider than a loss of $14.38 per share in the previous year.

— Research and development expenses remained flat from the last year at $4.6 million.

— General and administrative expenses were $4.1 million during the year ended December 31, 2019, up 21% from last year, primarily due to increased legal…

Bio-Path Holdings, Inc. (NASDAQ: BPTH): Q3 2019 Earnings Snapshot

— Bio-Path Holdings, Inc. (NASDAQ: BPTH) reported a net loss of $2.2 million or $0.78 share for the third quarter of 2019, vs. $0.74 per share loss expected.

— Research and development expenses decreased to $1.4 million from $2.3 million last year

— General and administrative expenses were $0.9 million during the three-month period, up 29% from last year

— Recorded cash of $15.4 million…

Bio-Path’s loss expands in Q2

Biotech company Bio-Path Holdings (NASDAQ: BPTH) reported a loss of $2.5 million or $0.87 per share for the second quarter ended June 30, 2019, compared to a loss of $1.7 million or $2.96 per share for the second quarter ended June 30, 2018. Bio-Path has not generated significant revenues to date. The company’s revenue generation in the future depends on the successful development and eventual…

Bio-Path likely to report wider Q2 loss on Aug. 15

Bio-Path Holdings (NASDAQ: BPTH) is expected to continue incurring significant operating losses in the second quarter. Also, the losses are likely to increase substantially as the biotech company expand its drug development programs and commercialization efforts. The company is set to release its second-quarter earnings results on Thursday before the bell.

The company had an accumulated deficit…

Bio-Path’s stock tanks as company delivers loss for Q1

Bio-Path Holdings Inc.’s (NASDAQ: BPTH) shares were down 2.6% in morning hours on Thursday after the company reported its first quarter 2019 earnings results.

The bio-tech company reported a net loss of $1.5 million, or $0.89 per share, for the quarter compared to a loss of $1.9 million, or $3.38 per share, in the prior-year period.

R&D expenses decreased to $0.4 million from $0.9…

Bio-Path Holdings (BPTH:NAS) and Iconix Brand Group (ICON:NAS) Are Biggest Stock Gainers YTD on NASDAQ

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Biggest Stock Gainers Year to Date on NASDAQ

Today we are looking at companies that have had the greatest…

Bio-Path Holdings Inc (Nasdaq:BPTH) Ends Down After Bouncy 53.33% Swing

Bio-Path Holdings Inc (Nasdaq:BPTH)

December 26th, 2018 Amidst rising markets Bio-Path Holdings Inc finished Wednesday’s trading session down 24.73%, a $0.05 decrease to close on $0.16. Bio-Path Holdings Inc swung 53.33% between low and high. As well as the drop in value, Bio-Path Holdings Inc hit a new 52 week low of $0.15, breaking the previous low of $0.17 from earlier this month. Two…

Breaking The Old 52 Week Low, Bio-Path Holdings Inc (Nasdaq:BPTH) Close At $0.23

Bio-Path Holdings Inc (Nasdaq:BPTH)

December 22nd, 2018 Amidst falling markets Bio-Path Holdings Inc closed the day up $0.05 Friday, a 26.03% increase, closing at $0.23. Despite ending the day higher, Bio-Path Holdings Inc hit a new 52 week low of $0.17. Bio-Path Holdings Inc bounced 35.29% between low and high. Two technical ‘scores’ for stocks to be aware of are the Altman Z1 and the Piotroski2…